CLINICAL_TRIALS
withdrawal
· 2022-09-21
Clinical Trial Update: Single Pill to Avert Cardiovascular Events [Phase 3]
Summary
Phase 3 cardiovascular trial was withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Hospital do Coracao | Conditions: Cardiovascular Disease | Phase 3 | Status: WITHDRAWN